Data gathered: October 7
Alternative Data for 10X Genomics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 67 | Sign up | Sign up | Sign up |
| Webpage traffic | 223,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 9 | Sign up | Sign up | Sign up |
| Facebook Followers | 15,644 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,732 | Sign up | Sign up | Sign up |
| Twitter Followers | 28,642 | Sign up | Sign up | Sign up |
| Twitter Mentions | 48 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,970 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 45 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,233 | Sign up | Sign up | Sign up |
About 10X Genomics
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific.
| Price | $11.60 |
| Target Price | Sign up |
| Volume | 2,870,000 |
| Market Cap | $1.59B |
| Year Range | $7.14 - $15.08 |
| Dividend Yield | 0% |
| Analyst Rating | 55% buy |
| Industry | Biotechnology |
In the news
 |
10x Genomics (NASDAQ:TXG) Receives $13.65 Average Price Target from BrokeragesOctober 4 - ETF Daily News |
|
10x Genomics (NASDAQ:TXG) Stock Rating Upgraded by Wall Street ZenOctober 4 - ETF Daily News |
 |
Analyzing Health Catalyst (NASDAQ:HCAT) and 10x Genomics (NASDAQ:TXG)October 2 - ETF Daily News |
|
Ballentine Partners LLC Acquires Shares of 15,574 10x Genomics $TXGOctober 1 - ETF Daily News |
|
10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A.September 23 - ETF Daily News |
|
Pallas Capital Advisors LLC Boosts Stake in 10x Genomics $TXGSeptember 20 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 173M | 48M | 125M | 35M | 47M | 0.280 |
| Q1 '25 | 155M | 49M | 105M | -34M | -39M | -0.280 |
| Q4 '24 | 165M | 54M | 111M | -49M | -38M | -0.140 |
| Q3 '24 | 152M | 45M | 106M | -36M | -24M | -0.020 |
| Q2 '24 | 153M | 46M | 107M | -38M | -26M | -0.320 |
Insider Transactions View All
| Hindson Benjamin J. filed to sell 440,888 shares at $13.8. August 26 '25 |
| Saxonov Serge filed to sell 945,892 shares at $13.8. August 26 '25 |
| Taich Adam filed to sell 309,273 shares at $13.8. August 26 '25 |
| Taich Adam filed to sell 331,588 shares at $8.3. May 27 '25 |
| Hindson Benjamin J. filed to sell 448,374 shares at $8.3. May 27 '25 |
Similar companies
Read more about 10X Genomics (TXG) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of 10X Genomics?
The Market Cap of 10X Genomics is $1.59B.
What is the current stock price of 10X Genomics?
Currently, the price of one share of 10X Genomics stock is $11.60.
How can I analyze the TXG stock price chart for investment decisions?
The TXG stock price chart above provides a comprehensive visual representation of 10X Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling 10X Genomics shares. Our platform offers an up-to-date TXG stock price chart, along with technical data analysis and alternative data insights.
Does TXG offer dividends to its shareholders?
As of our latest update, 10X Genomics (TXG) does not offer dividends to its shareholders. Investors interested in 10X Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of 10X Genomics?
Some of the similar stocks of 10X Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
